PANDA is transcribed antisense to CDKN1A (p21) and located in upstream of CDKN1A8, and CDKN1A functions as a regulator of cell cycle progression, therefore we set CCK-8 assay and EdU assay to evaluate PANDA’s role in cancer cell viability and proliferation. This evidence concerns the gene CDKN1A and cancer.